Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management
Summary Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background: The mucopolysaccharidoses are inherited metabolic conditi...
Saved in:
Published in | Pediatric anesthesia Vol. 22; no. 8; pp. 745 - 751 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2012
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome).
Background: The mucopolysaccharidoses are inherited metabolic conditions with a well‐documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management.
Methods/Materials: We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children’s Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia.
Results: There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group.
Conclusions: Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. |
---|---|
AbstractList | Aim:
To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome).
Background:
The mucopolysaccharidoses are inherited metabolic conditions with a well‐documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management.
Methods/Materials:
We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children’s Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia.
Results:
There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group.
Conclusions:
Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. Summary Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background: The mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. Methods/Materials: We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. Results: There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Conclusions: Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. [PUBLICATION ABSTRACT] To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome).AIMTo assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome).The mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management.BACKGROUNDThe mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management.We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia.METHODS/MATERIALSWe carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia.There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group.RESULTSThere were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group.Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.CONCLUSIONSManaging the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). The mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. Summary Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background: The mucopolysaccharidoses are inherited metabolic conditions with a well‐documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. Methods/Materials: We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children’s Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. Results: There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Conclusions: Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. |
Author | Kirkpatrick, Katherine Ellwood, James Walker, Robert W. M. |
Author_xml | – sequence: 1 givenname: Katherine surname: Kirkpatrick fullname: Kirkpatrick, Katherine organization: Royal Manchester Children's Hospital, Manchester, UK – sequence: 2 givenname: James surname: Ellwood fullname: Ellwood, James organization: Royal Manchester Children's Hospital, Manchester, UK – sequence: 3 givenname: Robert W. M. surname: Walker fullname: Walker, Robert W. M. organization: Royal Manchester Children's Hospital, Manchester, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22672476$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkttu1DAQhi1URNuFV0CWuClSs9hx7CRIIFUVtIVSkMrh0nKcCfU2sYOdaBueiwfE2W170atGjnz6v9_2zOyjHessIIQpWdL4vVktaSZIUvIyXaaEpkvCijJf3jxBe_cbO3FMOU-4yPgu2g9hRQhlqUifod00FXma5WIP_fsyate7dgpK6yvlTe2CCXiYesBn-OB09C14HCZbe9fBa6xsHX8IwxUEo97i2GPT9UoP2DW4itfEnfLerfHglQ19q-ygBuPsIQb7d-oAe4iLGjqww0x71U-HG9vGVOBdPxiNjR3GaoPh2JTxazVFX6t-b7jn6Gmj2gAvbvsF-vHxw_fj0-T868nZ8dF5ojPG86TMSUGLlBZxIhoumFKUNRoEECUqLhTU0Oi6yFSRU2BEUyEKkpe8YIIVqmILdLD17b37M8ZHy84EDW18FLgxSEpSxllGWRmlrx5IV270Nt5OUsayMhUi2i7Qy1vVWHVQy96bGK1J3uUjCt5vBdq7EDw0Uptt_GI4TRtPlHMByJWc8yznPMu5AOSmAORNNCgeGNyd8Qj03RZdmxamR3Py29HFPIp8suVNGODmnlf-Woqc5Vz-ujiRl_zyEy9_fo5R-Q-zG9no |
CitedBy_id | crossref_primary_10_1186_s13023_015_0255_4 crossref_primary_10_1111_pan_13640 crossref_primary_10_1007_s00540_016_2180_7 crossref_primary_10_1111_pan_12370 crossref_primary_10_4103_joacp_JOACP_532_20 crossref_primary_10_1177_0310057X1604400612 crossref_primary_10_3390_reports5010010 crossref_primary_10_1302_0301_620X_99B9_BJJ_2017_0487 crossref_primary_10_1111_pan_13787 crossref_primary_10_1016_j_ymgme_2014_03_013 crossref_primary_10_1093_bjaceaccp_mku004 crossref_primary_10_1016_j_redar_2012_12_008 crossref_primary_10_3390_jcm10163518 crossref_primary_10_1093_bja_aet411 crossref_primary_10_1016_j_bbmt_2019_02_012 crossref_primary_10_1148_rg_2016150168 crossref_primary_10_1186_s13052_018_0554_1 crossref_primary_10_1517_21678707_2015_1016908 crossref_primary_10_1177_2326409815616392 crossref_primary_10_7759_cureus_10582 crossref_primary_10_3390_biom11020189 crossref_primary_10_1007_s13691_024_00702_5 crossref_primary_10_1136_bcr_2012_008148 crossref_primary_10_1111_pan_13379 crossref_primary_10_1183_09059180_00008012 crossref_primary_10_1016_j_beem_2014_08_005 crossref_primary_10_3390_jcm10153275 crossref_primary_10_1371_journal_pone_0203216 crossref_primary_10_3390_ijms21082975 crossref_primary_10_12688_f1000research_23532_1 crossref_primary_10_1213_ANE_0000000000001689 crossref_primary_10_3390_cells9081838 crossref_primary_10_1007_s00381_018_3834_6 crossref_primary_10_1007_s10545_012_9563_1 crossref_primary_10_1016_j_ncl_2013_04_007 crossref_primary_10_1097_AIA_0000000000000131 |
Cites_doi | 10.1016/S0140-6736(81)91046-1 10.1016/j.ymgme.2006.08.007 10.1046/j.1460-9592.1997.d01-102.x 10.1038/sj.bmt.1705718 10.1097/01241398-200401000-00019 10.1016/j.amjcard.2006.02.047 10.1177/0310057X9602400408 10.1542/peds.2008-0416 10.1111/j.1365-2044.1994.tb04360.x 10.1046/j.1460-9592.2000.00425.x 10.1046/j.1460-9592.2003.00969.x 10.1016/j.jpeds.2004.01.046 10.1177/0310057X8301100303 |
ContentType | Journal Article |
Copyright | 2012 Blackwell Publishing Ltd 2012 Blackwell Publishing Ltd. Copyright 2012 Blackwell Publishing Ltd |
Copyright_xml | – notice: 2012 Blackwell Publishing Ltd – notice: 2012 Blackwell Publishing Ltd. – notice: Copyright 2012 Blackwell Publishing Ltd |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1111/j.1460-9592.2012.03897.x |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-9592 |
EndPage | 751 |
ExternalDocumentID | 2951047891 22672476 10_1111_j_1460_9592_2012_03897_x PAN3897 ark_67375_WNG_S5SJ59VK_1 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUOVR AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 NF~ O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 |
ID | FETCH-LOGICAL-c4357-9708182183576f563aa13fce6e0a6b56aedefcd84a871e30c1668079583638ab3 |
IEDL.DBID | DR2 |
ISSN | 1155-5645 1460-9592 |
IngestDate | Thu Jul 10 22:24:50 EDT 2025 Fri Jul 25 06:45:11 EDT 2025 Wed Feb 19 02:03:00 EST 2025 Tue Jul 01 02:22:25 EDT 2025 Thu Apr 24 22:54:15 EDT 2025 Wed Jan 22 16:36:07 EST 2025 Wed Oct 30 09:49:00 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2012 Blackwell Publishing Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4357-9708182183576f563aa13fce6e0a6b56aedefcd84a871e30c1668079583638ab3 |
Notes | istex:B0A966C41876BFA3751109DD9A61379A8168591C ark:/67375/WNG-S5SJ59VK-1 ArticleID:PAN3897 Section Editor: Brian Anderson ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 22672476 |
PQID | 1334926658 |
PQPubID | 1036358 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1023534139 proquest_journals_1334926658 pubmed_primary_22672476 crossref_citationtrail_10_1111_j_1460_9592_2012_03897_x crossref_primary_10_1111_j_1460_9592_2012_03897_x wiley_primary_10_1111_j_1460_9592_2012_03897_x_PAN3897 istex_primary_ark_67375_WNG_S5SJ59VK_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-08 August 2012 2012-08-00 2012-Aug 20120801 |
PublicationDateYYYYMMDD | 2012-08-01 |
PublicationDate_xml | – month: 08 year: 2012 text: 2012-08 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: France – name: Glasgow |
PublicationTitle | Pediatric anesthesia |
PublicationTitleAlternate | Paediatr Anaesth |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Moores C, Rogers JG, McKenzie IM et al. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1996; 24: 259-463. Hobbs JR, Hugh-Jones K, Barrett AJ et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-712. Boelens JJ, Wynn RF, O'Meara A et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225-233. Sifuentes M, Doroshow R, Hoft R et al. A follow -up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180. Weisstein JS, Delgado E, Steinbach LS et al. Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation. J Pediatr Orthop 2004; 24: 97-101. Walker RW, Darowski M, Morris P et al. Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia 1994; 49: 1078-1084. Walker RWM. The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation. Paediatr Anaesth 2000; 10: 53-58. Walker RWM, Colovic V, Robinson DN et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses. Paediatr Anaesth 2003; 13: 441-447. Wraith JE, Clarke LA, Beck M et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase). J Pediatr 2004; 144: 581-588. Walker RWM, Allen DL, Rothera M. A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway. Paediatr Anaesth 1997; 7: 421-426. Smith RM. Anaesthesia for Infants and Children, 4th edn. St Louis, MO: C.V. Mosby Co, 1980: 533-536. Baines D, Keneally J. Anaesthetic implications of the mucopolysaccharidoses: a fifteen-year experience in a children's hospital. Anaesth Intensive Care 1983; 11: 198-202. Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009; 123: 19-29. Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006; 98: 416-418. 2004; 144 2001 2006; 98 2000; 10 1981; 2 2004; 24 2003; 13 2007; 90 2009; 123 1994; 49 2007; 40 1980 1996; 24 1983; 11 1997; 7 e_1_2_7_4_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_13_2 e_1_2_7_12_2 Moores C (e_1_2_7_3_2) 1996; 24 e_1_2_7_11_2 e_1_2_7_10_2 Neufeld EF (e_1_2_7_9_2) 2001 Baines D (e_1_2_7_5_2) 1983; 11 Smith RM (e_1_2_7_2_2) 1980 |
References_xml | – reference: Hobbs JR, Hugh-Jones K, Barrett AJ et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-712. – reference: Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009; 123: 19-29. – reference: Sifuentes M, Doroshow R, Hoft R et al. A follow -up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180. – reference: Walker RW, Darowski M, Morris P et al. Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia 1994; 49: 1078-1084. – reference: Smith RM. Anaesthesia for Infants and Children, 4th edn. St Louis, MO: C.V. Mosby Co, 1980: 533-536. – reference: Walker RWM. The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation. Paediatr Anaesth 2000; 10: 53-58. – reference: Walker RWM, Allen DL, Rothera M. A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway. Paediatr Anaesth 1997; 7: 421-426. – reference: Weisstein JS, Delgado E, Steinbach LS et al. Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation. J Pediatr Orthop 2004; 24: 97-101. – reference: Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006; 98: 416-418. – reference: Moores C, Rogers JG, McKenzie IM et al. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1996; 24: 259-463. – reference: Wraith JE, Clarke LA, Beck M et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase). J Pediatr 2004; 144: 581-588. – reference: Boelens JJ, Wynn RF, O'Meara A et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225-233. – reference: Walker RWM, Colovic V, Robinson DN et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses. Paediatr Anaesth 2003; 13: 441-447. – reference: Baines D, Keneally J. Anaesthetic implications of the mucopolysaccharidoses: a fifteen-year experience in a children's hospital. Anaesth Intensive Care 1983; 11: 198-202. – volume: 2 start-page: 709 year: 1981 end-page: 712 article-title: Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone‐marrow transplantation publication-title: Lancet – volume: 7 start-page: 421 year: 1997 end-page: 426 article-title: A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway publication-title: Paediatr Anaesth – volume: 24 start-page: 259 year: 1996 end-page: 463 article-title: Anaesthesia for children with mucopolysaccharidoses publication-title: Anaesth Intensive Care – volume: 11 start-page: 198 year: 1983 end-page: 202 article-title: Anaesthetic implications of the mucopolysaccharidoses: a fifteen‐year experience in a children’s hospital publication-title: Anaesth Intensive Care – volume: 24 start-page: 97 year: 2004 end-page: 101 article-title: Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation publication-title: J Pediatr Orthop – volume: 10 start-page: 53 year: 2000 end-page: 58 article-title: The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation publication-title: Paediatr Anaesth – volume: 49 start-page: 1078 year: 1994 end-page: 1084 article-title: Anaesthesia and mucopolysaccharidoses. A review of airway problems in children publication-title: Anaesthesia – start-page: 3421 year: 2001 end-page: 3452 – volume: 123 start-page: 19 year: 2009 end-page: 29 article-title: Mucopolysaccharidosis I: management and treatment guidelines publication-title: Pediatrics – volume: 144 start-page: 581 year: 2004 end-page: 588 article-title: Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double‐blinded, placebo‐controlled, multinational study of recombinant human α‐l‐iduronidase (laronidase) publication-title: J Pediatr – volume: 40 start-page: 225 year: 2007 end-page: 233 article-title: Outcomes of hematopoietic stem cell transplantation for Hurler’s syndrome in Europe: a risk factor analysis for graft failure publication-title: Bone Marrow Transplant – volume: 90 start-page: 171 year: 2007 end-page: 180 article-title: A follow –up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years publication-title: Mol Genet Metab – volume: 13 start-page: 441 year: 2003 end-page: 447 article-title: Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses publication-title: Paediatr Anaesth – volume: 98 start-page: 416 year: 2006 end-page: 418 article-title: Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I publication-title: Am J Cardiol – start-page: 533 year: 1980 end-page: 536 – ident: e_1_2_7_6_2 doi: 10.1016/S0140-6736(81)91046-1 – ident: e_1_2_7_13_2 doi: 10.1016/j.ymgme.2006.08.007 – ident: e_1_2_7_8_2 doi: 10.1046/j.1460-9592.1997.d01-102.x – ident: e_1_2_7_11_2 doi: 10.1038/sj.bmt.1705718 – ident: e_1_2_7_12_2 doi: 10.1097/01241398-200401000-00019 – ident: e_1_2_7_14_2 doi: 10.1016/j.amjcard.2006.02.047 – volume: 24 start-page: 259 year: 1996 ident: e_1_2_7_3_2 article-title: Anaesthesia for children with mucopolysaccharidoses publication-title: Anaesth Intensive Care doi: 10.1177/0310057X9602400408 – ident: e_1_2_7_10_2 doi: 10.1542/peds.2008-0416 – ident: e_1_2_7_4_2 doi: 10.1111/j.1365-2044.1994.tb04360.x – start-page: 533 volume-title: Anaesthesia for Infants and Children year: 1980 ident: e_1_2_7_2_2 – ident: e_1_2_7_15_2 doi: 10.1046/j.1460-9592.2000.00425.x – ident: e_1_2_7_16_2 doi: 10.1046/j.1460-9592.2003.00969.x – ident: e_1_2_7_7_2 doi: 10.1016/j.jpeds.2004.01.046 – start-page: 3421 volume-title: The Metabolic and Molecular Basis of Inherited Disease year: 2001 ident: e_1_2_7_9_2 – volume: 11 start-page: 198 year: 1983 ident: e_1_2_7_5_2 article-title: Anaesthetic implications of the mucopolysaccharidoses: a fifteen‐year experience in a children’s hospital publication-title: Anaesth Intensive Care doi: 10.1177/0310057X8301100303 |
SSID | ssj0013262 |
Score | 2.1620421 |
Snippet | Summary
Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique... Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in... To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients... Summary Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 745 |
SubjectTerms | Adolescent Airway management Airway Management - methods Anesthesia Bone marrow Bone Marrow Transplantation - methods Child Child, Preschool difficult airway Enzyme Replacement Therapy Female Fiber Optic Technology Humans Hurler syndrome Infant Intubation Laryngeal Masks Laryngoscopy Male mucopolysaccharidoses Mucopolysaccharidosis I - physiopathology Mucopolysaccharidosis I - surgery Mucopolysaccharidosis I - therapy Patients Retrospective Studies Transplants & implants Treatment Failure |
Title | Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management |
URI | https://api.istex.fr/ark:/67375/WNG-S5SJ59VK-1/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1460-9592.2012.03897.x https://www.ncbi.nlm.nih.gov/pubmed/22672476 https://www.proquest.com/docview/1334926658 https://www.proquest.com/docview/1023534139 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELbQJiFeYPxc2JiMhBBIS5U0sZ3w1gGlDLVCjMHeLMe5iKprippWrPu7-AO5c9KITnuYEFKjRm0vjePz3efz3WfGXpgY3SZRzoaZkn6cQ-obRMl-loJKJORRBBTvGI7k4DQ-PhNnTf4T1cLU_BBtwI1GhrPXNMBNVl0d5IGfipTqqSikh75XdQhPUuoW4aMv3b8WFNzeooh_hE8EKptJPddeaMNTbdNDv7gOhm6iWueW-vfYZN2gOhtl0lkuso69vML1-H9avMPuNuiV92p1u89uQfmA3R426_MP2e_h0tKuC6vKWKrnGuezalxxivPyj_zVAO8I5nzNkvCamzLHA9v5A6qxecPxndd1m3xW8GxWAp86lki-cCTs56aulCoPOZSXqynwObisMopx8rqWbHXoLlu4VBg0iJaP0a9mTozjy4znv8yKT9u8n0fstP_-69uB3-wL4VsEd8pPFfHwEbbDyVIhZGRMGBUWJARGZkIayKGweRIbnA1CFNhQyiRQqUgitDYmix6zrRJbsMs4igogl5zGIg6DIiF-_64KbAIQJhY8ptY6oG1Dmk57d5zrjclToKlTNHWKdp2iLzwWtpI_a-KQG8i8dGrWCpj5hBLvlNDfRx_0iTg5Fum3Tzr02P5aD3VjcyodRsQ0KRFSeux5-zVaC1oCwr6cLfE3RG9EwCX12JNaf9s_QyCuurGSHpNOC2982_pzb0RnT_9VcI_doY_rvMp9trWYL-EZYr1FdsC2e0fvjvoHbjT_AYk8Rsk |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1tb9MwELbQJgFfeH8JDDASQiAtVdLEdsK3CTG6l1aIbbBvluNcRLU2RUkr1v0ufiB3ThrRaR8mhNSolZpL4vjse3y-e46xNyZGs0mUs2GmpB_nkPoGUbKfpaASCXkUAfk7hiM5OIn3T8VpWw6IcmEafojO4UYjw83XNMDJIX15lAd-KlJKqCKfHhpf1UNAuUkFvt366mv_ry0FV10UEZDwiUJlPaznyiut2apNeu3nVwHRdVzrDNPuXTZZNamJRznrLeZZz15cYnv8T22-x-60AJbvNBp3n92A8gG7OWy36B-y38OFpcILy9pYSuka57N6XHNy9fI9_m6AjwQVXxElvOemzPHAhv6Aemw-cPzmTeomnxU8m5XAp44oks8dD_vENMlS5TaH8mI5BV6BCywjNydv0smW2-6yhYuGwTnR8jGa1syJcfyYcfXLLPm0C_15xE52Px1_HPhtaQjfIr5TfqqIio_gHa6XCiEjY8KosCAhMDIT0kAOhc2T2OCCEKLAhlImgUpFEuGEY7LoMdsosQVPGUdRAWSV01jEYVAkRPHfV4FNAMLEgsfUSgm0bXnTqXzHRK-tnwJNnaKpU7TrFH3usbCT_Nlwh1xD5q3Ts07AVGcUe6eE_j76rI_E0b5Ivx3o0GNbK0XU7bRT6zAiskmJqNJjr7u_ccKgXSDsy9kCzyGGI8IuqceeNArc3QyxuOrHSnpMOjW89mPrLzsj-vXsXwVfsVuD4-GhPtwbHTxnt-mUJsxyi23MqwW8QOg3z166If0HnYFJcg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1tb9MwELbQJk184f0lMMBICIG0VEkT2wnfJkbpNlpNjMG-WY5zEVXXdGpase538QO5c9KITvswIaRGrdJcGtfnu8fnu8eMvTExuk2inA0zJf04h9Q3iJL9LAWVSMijCCjeMRjK_kl8cCpOm_wnqoWp-SHagBuNDGevaYCf58XVQR74qUipnopCeuh7VQfx5CaeT0jD9752_1pRcJuLIgASPjGorGf1XHunNVe1Sf_6xXU4dB3WOr_Uu8vGqxbV6SjjzmKedezlFbLH_9Pke-xOA1_5bq1v99ktKB-wrUGzQP-Q_R4sLG27sKyMpYKuUT6tRhWnQC_f5-_6-EQw4yuahPfclDke2M6fUI3MB47vvC7c5NOCZ9MS-MTRRPK5Y2E_M3WpVLnDobxcToDPwKWVUZCT18Vkyx1328LlwqBFtHyEjjVzYhxfZjT7ZZZ80ib-PGInvU_fPvb9ZmMI3yK6U36qiIiPwB3OlgohI2PCqLAgITAyE9JADoXNk9jgdBCiwIZSJoFKRRKhuTFZ9JhtlNiCp4yjqADyyWks4jAoEiL476rAJgBhYsFjaqUD2jas6bR5x5lemz0FmjpFU6do1yn6wmNhK3leM4fcQOatU7NWwMzGlHmnhP4x_KyPxfGBSL8f6tBj2ys91I3RqXQYEdWkREzpsdft12guaA0I-3K6wGuI34iQS-qxJ7X-tj-GSFx1YyU9Jp0W3vix9dHukD49-1fBV2zraK-nv-wPD5-z23RFnWO5zTbmswW8QNw3z166Af0HlwZIKg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mucopolysaccharidosis+type+I+%28Hurler+syndrome%29+and+anesthesia%3A+the+impact+of+bone+marrow+transplantation%2C+enzyme+replacement+therapy%2C+and+fiberoptic+intubation+on+airway+management&rft.jtitle=Pediatric+anesthesia&rft.au=Kirkpatrick%2C+Katherine&rft.au=Ellwood%2C+James&rft.au=Walker%2C+Robert+W+M&rft.date=2012-08-01&rft.issn=1460-9592&rft.eissn=1460-9592&rft.volume=22&rft.issue=8&rft.spage=745&rft_id=info:doi/10.1111%2Fj.1460-9592.2012.03897.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1155-5645&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1155-5645&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1155-5645&client=summon |